Tested Applications
| Positive WB detected in | HeLa cells |
| Positive IP detected in | HeLa cells |
| Positive IHC detected in | human placenta tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | HeLa cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:200-1:1000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
25228-1-AP targets ZNF451 in WB, IHC, IF/ICC, IP, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag18346 Product name: Recombinant human ZNF451 protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 1-350 aa of BC021712 Sequence: MGDPGSEIIESVPPAGPEASESTTDENEDDIQFVSEGPLRPVLEYIDLVSSDDEEPSTSYTDENIKRKDHIDYQKDKVALTLARLARHVEVEKQQKEEKNRAFREKIDFQHAHGLQELEFIRGHSDTEAARLCVDQWLKMPGLKTGTINCGTKSSFRRGGHTWVSGKPILCPIMHCNKEFDNGHLLLGHLKRFDHSPCDPTITLHGPFFSSFACVVCYKKFVTQQQYRDHLFDKEATDDGHNNNLLPQIIQCFACPNCFLLFSRKEECSKHMSGKNHFHQSFKLGDNKGIAHPISFPSFAKKLLISLCKDVPFQVKCVACHKTLRSHMELTAHFRVHCRNAGPVAVAEKS Predict reactive species |
| Full Name | zinc finger protein 451 |
| Calculated Molecular Weight | 1061 aa, 121 kDa |
| Observed Molecular Weight | 121 kDa |
| GenBank Accession Number | BC021712 |
| Gene Symbol | ZNF451 |
| Gene ID (NCBI) | 26036 |
| RRID | AB_2879975 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9Y4E5 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for ZNF451 antibody 25228-1-AP | Download protocol |
| IHC protocol for ZNF451 antibody 25228-1-AP | Download protocol |
| IP protocol for ZNF451 antibody 25228-1-AP | Download protocol |
| WB protocol for ZNF451 antibody 25228-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The ZNF451 Polyclonal antibody (Cat# 25228-1-AP) has 6 total citations. These appear in Research, Oncogene, Cell Reports, Respiratory Research, Frontiers in Cell and Developmental Biology, and PLoS Pathogens. The associated research fields span oncology (drug resistance, bladder cancer, triple-negative breast cancer), pulmonary fibrosis, spermatogenesis, and viral infection (Epstein-Barr virus), with applications primarily in Western blot, IHC, and IF.
| Species | Application | Title |
|---|---|---|
Research (Wash D C) Single-Cell Spatial-Temporal Analysis of ZNF451 in Mediating Drug Resistance and CD8+ T Cell Dysfunction | ||
Oncogene YME1L1 degradation by TRIM21 inhibits bladder cancer proliferation, metastasis, and mitochondrial function. | ||
Cell Rep ZNF451 favors triple-negative breast cancer progression by enhancing SLUG-mediated CCL5 transcriptional expression
| ||
Front Cell Dev Biol NSMCE2 dispensability in mouse spermatogenesis suggests functional redundancy within the meiotic repair network. | ||
PLoS Pathog Changes in SUMO-modified proteins in Epstein-Barr virus infection identifies reciprocal regulation of TRIM24/28/33 complexes and the lytic switch BZLF1 |















